Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models

Dezhi Li(NYU Langone Health), Hua Zhang(University of Hong Kong), Alice H. Berger(Fred Hutch Cancer Center), Christina C. Kuismi(Fred Hutch Cancer Center), Fiona Sherman(NYU Langone Health), Jiajia Gu(Jiangsu Cancer Hospital), Nathanael S. Gray(Stanford University), Shengqing Gu(Dana-Farber Cancer Institute), Saurav Kumar(Arizona State University), Cassandra Thakurdin(NYU Langone Health), Behnam Nabet(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Magdalena A. Ploszaj(NYU Langone Health), Annabel T. Olson(Fred Hutch Cancer Center), Mary Meynardie(NYU Langone Health), Michela Ranieri(NYU Langone Health), Tullia C. Bruno(University of Pittsburgh), Joy Chen(University of California San Diego), Benjamin A. Nacev(University of Pittsburgh), Hu Baoli(University of Pittsburgh), Janaye Stephens(NYU Langone Health), Xuejiao Sun(UPMC Hillman Cancer Center), Kwok-Kin Wong(NYU Langone Health), Jaylen M. Powell(NYU Langone Health), Ke Geng(Rutgers, The State University of New Jersey), Hye Mi Kim(University of Pittsburgh), Jing Li(Nanjing University), Wei Chen(University of Pittsburgh), Yang Liu(Nankai University), Ting Chen(Nanchang University), Yiting Li(UPMC Hillman Cancer Center), Daniel Levin(NYU Langone Health), Xuerui Wang(Nanjing Tech University), Han Han(Shanghai Medical College of Fudan University), Ze-Yan Zhang(Wuhan University), Yuanwang Pan(NYU Langone Health), Hao Yuan(Office of Science), Tinghu Zhang(Stanford University), Xiaoyang Zhang(Northwestern University), Medard Ernest Kaiza(University of Pittsburgh), Asia M. Williams(University of Pittsburgh), Alison Chafitz(NYU Langone Health), Mia S. Donald-Paladino(Fred Hutch Cancer Center), Fei Li(Nanfang Hospital)
Journal of Clinical Investigation
December 24, 2024
Cited by 16


Related Papers